Facebook
X
LinkedIn
ForwardQuestion and Answer Session 6
Needs Statement
Updating practicing physicians and other health professionals in both the diagnosis and management of gastrointestinal and liver diseases/conditions is essential to providing quality care leading to improved patient outcomes. This activity is designed to increase knowledge,improve competence, and enhance performance of the physician learners in practice to ultimately better patient care and outcomes in gastroenterology.
Target Audience
Gastroenterologists, hepatologists, internists, primary care physicians, nurses, nurse practitioners, physician assistants, fellows, medical trainees and students in the field of Gastroenterology.
Learning Objectives
At the conclusion of the session, the participants should be able to:
- Outline new drugs and treatment strategies for inflammatory bowel disease (IBD), including biologics, biomarkers, management during pregnancy, and addressing treatment failures.
- Review advances in managing irritable bowel syndrome (IBS), chronic constipation, primary biliary cirrhosis (PBC), MASLD/MASH, opioid use disorder, and other gastrointestinal conditions.
- Highlight procedural innovations, such as intestinal ultrasound for IBD, computer-aided colonoscopy, PEG tube placement, endoscopic submucosal dissection, Barrett’s ablation, cold EMR, and luminal stricture dilations.
- Summarize strategies for diagnosing and managing colorectal cancer, including endoscopic ultrasound and non-invasive diagnostics like the Cologuard/FIT DNA test.
- Recognize and appropriately manage opioid misuse in patients with gastrointestinal diseases while navigating ethical challenges and barriers to care.
Physician
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the
Nursing
Texas Children’s Hospital is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This NCPD activity awards 0.25 contact hours.
Nursing Learning Outcome Statement
Upon completion of the professional development activity, at least 75% of participants will report that the activity increased or validated their knowledge and can be applied to their practice in support of improving patient care and outcomes in gastroenterology.
Requirements for Successful Completion
To receive contact hours for this nursing continuing professional development (NCPD) activity, the participant must:
- Attend at least one session
- Complete a participant evaluation online
Disclosure Policy for Nursing Credit
Texas Children's Hospital (TCH) is accredited by the American Nurses Credentialing Center (ANCC). TCH is committed to accrediting continuing education activities that are evidence-based, accurate, current, and objectively presented.
In accordance with the ANCC Standards for Integrity & Independence in Accrediting Continuing Education, TCH has implemented an assessment mechanism requiring everyone in a position to control the content of an educational activity (i.e., nurse planners, subject matter experts, planning committee members, faculty) to disclose any relevant financial relationships with ineligible companies and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of relevant financial relationships at the time of the activity or within 24 months prior to the activity. If at any time during this activity you feel that there has been commercial/promotional bias, please notify the Nurse Planner.
All of the relevant financial relationships listed for these individuals have been mitigated.
Available Credit
- 0.25 AMA PRA Category 1 Credit™
- 0.25 ANCC
- 0.25 Participation